Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7600+0.0500 (+2.92%)
At close: 04:00PM EDT
1.7400 -0.02 (-1.14%)
After hours: 07:42PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.33M
Enterprise Value 3.24M
Trailing P/E 0.01
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.11
Price/Book (mrq)1.78
Enterprise Value/Revenue 0.20
Enterprise Value/EBITDA -0.20

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3-87.82%
S&P500 52-Week Change 318.47%
52 Week High 316.0000
52 Week Low 31.6500
50-Day Moving Average 32.4185
200-Day Moving Average 37.2626

Share Statistics

Avg Vol (3 month) 348.9k
Avg Vol (10 day) 341.38k
Shares Outstanding 51.93M
Implied Shares Outstanding 61.93M
Float 81.8M
% Held by Insiders 13.41%
% Held by Institutions 11.04%
Shares Short (Aug 30, 2023) 410.65k
Short Ratio (Aug 30, 2023) 40.24
Short % of Float (Aug 30, 2023) 40.55%
Short % of Shares Outstanding (Aug 30, 2023) 40.55%
Shares Short (prior month Jul 30, 2023) 438.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Apr 10, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023


Profit Margin -116.82%
Operating Margin (ttm)-161.20%

Management Effectiveness

Return on Assets (ttm)-72.40%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)16.31M
Revenue Per Share (ttm)15.31
Quarterly Revenue Growth (yoy)158.80%
Gross Profit (ttm)N/A
EBITDA -25.75M
Net Income Avi to Common (ttm)-19.06M
Diluted EPS (ttm)126.9100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.79M
Total Cash Per Share (mrq)1.45
Total Debt (mrq)2.69M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.76
Book Value Per Share (mrq)-7.39

Cash Flow Statement

Operating Cash Flow (ttm)-28.38M
Levered Free Cash Flow (ttm)-19.91M